Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression
Titel:
Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression
Auteur:
Aguilar, E.J. Ricciuti, B. Gainor, J.F. Kehl, K.L. Kravets, S. Dahlberg, S. Nishino, M. Sholl, L.M. Adeni, A. Subegdjo, S. Khosrowjerdi, S. Peterson, R.M. Digumarthy, S. Liu, C. Sauter, J. Rizvi, H. Arbour, K.C. Carter, B.W. Heymach, J.V. Altan, M. Hellmann, M.D. Awad, M.M.